Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma - Jedd D. Wolchok; Vanna Chiarion-Sileni; Piotr Rutkowski; C. Lance Cowey; Dirk Schadendorf; John Wagstaff; Paola Queirolo; Reinhard Dummer; Marcus O. Butler; Andrew G. Hill; Michael A. Postow; Caroline Gaudy-Marqueste; et al. (New England Journal of Medicine, 2025)